Mary Ann Ottinger

Adverse Outcome Pathway (AOP) Development I: Strategies and Principles

Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero et al. · Toxicological Sciences · 2014 · 680 citations · Full text

Aging in Rhesus Monkeys: Relevance to Human Health Interventions

George S. Roth, Julie A. Mattison, Mary Ann Ottinger et al. · Science · 2004 · 358 citations

Lifespan Extension, Primatology, Aging +13

GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

Yazhou Li, Kara B. Duffy, Mary Ann Ottinger et al. · Journal of Alzheimer s Disease · 2010 · 319 citations · Full text

Adverse Outcome Pathway Development II: Best Practices

Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero et al. · Toxicological Sciences · 2014 · 250 citations · Full text

Adverse Event, Biostatistics, Public Health +17

Sex steroid levels in developing and adult male and female zebra finches (Poephila guttata)

Elizabeth Adkins–Regan, Mahmoud Abdelnabi, Mohammed Mobarak et al. · General and Comparative Endocrinology · 1990 · 238 citations